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Abstract
Aim: We explored the anti-arrhythmic efﬁcacy of K
+ channel activation in
the hypokalaemic murine heart using NS1643 and nicorandil, compounds
which augment IKr and IKATP respectively.
Methods: Left ventricular epicardial and endocardial monophasic action
potentials were compared in normokalaemic and hypokalaemic preparations
in the absence and presence of NS1643 (30 lm) and nicorandil (20 lm).
Results: Spontaneously beating hypokalaemic hearts (3 mm K
+) all elicited
early afterdepolarizations (EADs) and episodes of ventricular tachycardia
(VT). Perfusion with NS1643 and nicorandil suppressed EADs and VT in 7
of 13 and ﬁve of six hypokalaemic hearts. Provoked arrhythmia studies using
programmed electrical stimulation induced VT in all hypokalaemic hearts,
but failed to do so in 7 of 13 and ﬁve of six hearts perfused with NS1643 and
nicorandil respectively. These anti-arrhythmic effects were accompanied by
reductions in action potential duration at 90% repolarization (APD90) and
changes in the transmural gradient of repolarization, reﬂected in DAPD90.
NS1643 and nicorandil reduced epicardial APD90 from 68.3  1.1 to
56.5  4.1 and 51.5  1.5 ms, respectively, but preserved endocardial
APD90 in hypokalaemic hearts. NS1643 and nicorandil thus restored
DAPD90 from )9.6  4.3 ms under baseline hypokalaemic conditions to
3.9  4.1 and 9.9  2.1 ms, respectively, close to normokalaemic values.
Conclusion: These ﬁndings demonstrate, for the ﬁrst time, the anti-ar-
rhythmic efﬁcacy of K
+ channel activation in the setting of hypokalaemia.
NS1643 and nicorandil are anti-arrhythmic through the suppression of
EADs, reductions in APD90 and restorations of DAPD90.
Keywords hypokalaemia, mouse heart, nicorandil, NS1643.
Cardiac arrhythmias are one of the leading causes of
morbidity and mortality in the developed world,
accounting for up to 70 000 deaths per year in the
UK (NICE, 2000). Long QT syndrome (LQTS) is a
disorder of impaired ventricular repolarization that
predisposes individuals to the development of lethal
arrhythmic episodes (Keating & Sanguinetti 2001):
congenital LQTS is predominantly caused by loss-
of-function mutations in HERG or KCNQ1 K
+ chan-
nel genes (Keating & Sanguinetti 2001). However,
inheritable arrhythmias comprising LQTS account for
only 1–2% of lethal ventricular arrhythmias seen
clinically (Kuo et al. 2001); thus other important risk
factors such as acquired forms of LQTS (Roden 2004)
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important role in the induction of arrhythmogenesis.
We have recently developed an intact murine whole
heart model of hypokalaemia-induced arrhythmogene-
sis that shows action potential prolongation and
altered transmural gradients of repolarization along-
side early afterdepolarizations (EADs) and ventricular
tachycardia (VT) (Killeen et al. 2007a). At the single
cell level, hypokalaemia signiﬁcantly reduced transient
outward (Ito) and inward rectiﬁer (IK1)K
+ currents,
effects which accounted for prolonged action potential
durations (APD) reported at the whole heart level
(Killeen et al. 2007a).
Improving cardiac repolarization through activation
of K
+ channels, therefore, could potentially negate
lethal arrhythmic episodes encountered under congen-
ital and acquired LQTS and in hypokalaemia by
enhancing outward repolarizing K
+ current. Such
actions would be expected to reduce APD and electro-
cardiographic QT interval, which may act to reduce the
occurrence of EADs, critical initiation factors in the
pathogenesis of VT (Killeen et al. 2007a,b). Pharma-
cological activation of K
+ channels is a potentially
novel anti-arrhythmic mechanism of action for the
treatment of life-threatening arrhythmias in the setting
of hypokalaemia. Recently, a novel and speciﬁc acti-
vator of the human ether-a-go-go related gene (HERG)
K
+ channel, NS1643, has been reported (Hansen et al.
2006). NS1643 has been shown to enhance the
magnitude of HERG current through reductions in
channel inactivation (Casis et al. 2006), and to reduce
APD in isolated ventricular myocytes (Hansen et al.
2006). Nicorandil is an activator of KATP channels that
was previously used as an antianginal agent. More
recently, however, reports have suggested that nico-
randil is an effective anti-arrhythmic agent in the
setting of LQTS (Shimizu et al. 1998, Shimizu &
Antzelevitch 2000).
The purpose of this study was to characterize the
anti-arrhythmic efﬁcacy of HERG K
+ channel activation
by NS1643 and KATP K
+ channel activation by nico-
randil in the setting of the common clinical condition of
hypokalaemia, using a recently developed murine whole
heart model of hypokalaemia-induced arrhythmogene-
sis (Killeen et al. 2007a). First, we demonstrated that
NS1643 and nicorandil reduce the occurrence of EADs
and episodes of spontaneous, unprovoked VT in the
hypokalaemic murine heart. Secondly, we quantiﬁed
the anti-arrhythmic efﬁcacy of NS1643 and nicorandil
in the hypokalaemic murine heart by using an estab-
lished clinical method of arrhythmia provocation.
Premature stimuli successfully initiated VT in all
hypokalaemic hearts, but failed to do so in 7 of 13
hearts treated with NS1643 and in ﬁve of six hearts
treated with nicorandil. Finally, we report that NS1643
and nicorandil reduce epicardial APD in the murine
heart, actions which restore the expected transmural
gradient of repolarization in the hypokalaemic murine
left ventricle. Collectively, these ﬁndings describe the
anti-arrhythmic efﬁcacy of HERG and KATP K
+ channel
activation in the setting of hypokalaemia for the ﬁrst
time in any cardiac preparation.
Methods
Experimental animals
The mice used in this study were kept in an animal
house at room temperature and subjected to a
consistent 12 h : 12 h light : dark cycle and fed
sterile rodent chow, having access to water at all
times. Wild-type (WT) 129 background male and
female mice, aged 5–7 months, were used in all
experiments.
Langendorff-perfused preparation
The experiments used a Langendorff-perfused prepa-
ration that was previously adapted for murine hearts
(Balasubramaniam et al. 2003). Brieﬂy, mice were
killed by cervical dislocation in accordance with
Schedule 1 of the UK Animals (Scientiﬁc Procedures)
Act 1986. The heart was then quickly excised and
submerged in ice-cold bicarbonate-buffered Krebs-
Henseleit solution containing in mm: 119 NaCl, 25
NaHCO3, 4 KCl, 1.2 KH2PO4, 1 MgCl2, 1.8 CaCl2,
10 glucose and 2 sodium pyruvate. The solution was
bubbled with a 95% O2–5% CO2 mixture (British
Oxygen Company, Manchester, UK). The aorta was
cannulated under the buffer surface using a 21-gauge
custom-made cannula, and was attached to the
cannula needle using a micro aneurysm clip (Harvard
Apparatus, Edenbridge, UK). The preparation was
then transferred to the perfusion apparatus, to which
the cannula was attached, and perfusion commenced
in a retrograde manner via the aorta with the above-
mentioned bicarbonate-buffered Krebs-Henseleit solu-
tion. Before entering the aorta, the buffer was passed
through 200 and 5 lm ﬁlters (Millipore, Watford,
UK) and warmed to 37  C by means of a water
jacket and circulator (model C-85A; Techne, Cam-
bridge, UK). Perfusion was maintained at a constant
ﬂow rate of 2–2.5 mL min
)1 using a peristaltic pump
(Watson-Marlow Bredel pumps model 505S; Fal-
mouth, Cornwall, UK). Following the start of perfu-
sion, healthy, experimentally viable hearts regained a
pink coloration and spontaneous rhythmic contraction
with warming. In 10% of experiments, hearts were
discarded because of signs of ischaemia after cannu-
lation and perfusion.
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In the present experiments, a paired (1 mm inter-pole
spacing) platinum-stimulating electrode was placed on
the basal surface of the right ventricular epicardium.
Prior to experimental procedures, hearts were paced for
10 min at 8 Hz using 2 ms square-wave stimuli with
amplitudes set to three times the excitation threshold
(Grass S48 stimulator; Grass-Telefactor, Slough, UK).
Epicardial monophasic action potential (MAP)
recordings were obtained using a MAP electrode
(Linton Instruments, Harvard Apparatus) placed on
the basal surface of the left ventricular epicardium. The
epicardial MAP electrode was gradually positioned until
a gentle but stable contact pressure was achieved. This
resulted in a recording of MAP signals. For endocardial
recordings, a small access window was created in the
interventricular septum to gain access to the left
ventricular endocardium (Casimiro et al. 2001). A
custom-made endocardial MAP electrode constructed
from two twisted strands of Teﬂon-coated (0.25 mm
diameter) silver wire (99.99% purity) (Advent Research
Materials Ltd, Oxford, UK) that had been previously
galvanically chlorided to eliminate DC offset was
positioned on to the left ventricular free wall under a
stable contact pressure until MAP signals were
achieved. MAPs were ampliﬁed, band-pass ﬁltered
(30 Hz to 1 kHz: Gould 2400S; Gould-Nicolet Tech-
nologies, Ilford, Essex, UK) and digitized (1401 plus
MKII; Cambridge Electronic Design, Cambridge, UK).
MAPs were extracted and analysed (Spike II version 4:
Cambridge Electronic Design) to derive the precise
duration of the digitized signals. The recordings were
deemed reproducible and, hence of an acceptable
standard for analysis, if they had the following prop-
erties: a stable baseline, a rapid upstroke phase with
consistent amplitude, a smooth contoured repolariza-
tion phase and a stable duration (MAP duration at 90%
repolarization (APD90) was reproducible within 3 ms
under baseline conditions).
Experimental protocol
A standard pacing protocol (basic cycle length, BCL of
125 ms) that corresponded to physiological whole
animal heart rates (Papadatos et al. 2002) was initiated
for periods of up to 20 min to measure APD at 50%,
70% and 90% repolarization. External pacing stimuli
were subsequently withdrawn from all preparations,
leading to a signiﬁcantly reduced, intrinsic heart rate
corresponding to a BCL of approximately 400 ms.
Reduced heart rates are a known risk factor for the
development of repolarization abnormalities such as
EADs and triggered beats that may underlie the
induction of VT (Roden & Hoffman 1985). Epicardial
MAPs were recorded for up to 20 min from isolated,
perfused WT mouse hearts under intrinsic pacing
conditions. Following this, programmed electrical stim-
ulation (PES) of the heart was carried out using an
adaptation of the corresponding clinical techniques
(Saumarez & Grace 2000, Balasubramaniam et al.
2003). PES procedures began by applying standard
pacing stimuli at a BCL of 125 ms for 25 s. Following
this, a drive train of eight paced beats (S1) again at a
BCL of 125 ms preceded an extrastimulus (S2) every
ninth beat. S1S2 intervals initially equalled the pacing
interval and then were progressively reduced by 1 ms
with each nine beat cycle until ventricular refractoriness
was reached, at which point the S2 stimulus elicited no
MAP. Recordings were subsequently repeated following
a 20-min wash-in of a reduced [K
+]o perfusate, of 3 mm
in the absence and presence of NS1643 (30 lm)o r
nicorandil (20 lm).
To quantify changes in transmural gradients of
repolarization, DAPD90 was calculated from the differ-
ence between the mean endocardial and epicardial
APD90 values, giving positive results where the endo-
cardial value exceeded the epicardial value, and nega-
tive results where the epicardial value was greater. An
EAD was deﬁned as a positive deﬂection that inter-
rupted the smooth repolarization phase of the AP.
A triggered beat was similarly described as a positive
deﬂection in the smooth repolarization phase of the
action potential whose amplitude approximately
matched the amplitude of the initial action potential.
Arrhythmias were deﬁned as ventricular tachyarrhyth-
mias of more than ﬁve cycles in duration that were
typically self-terminating. Following cannulation and
subsequent perfusion of hearts, approximately 10% of
preparations were discarded because of signs of ischae-
mia. Preliminary experiments revealed that there were
no gender-related effects in the response to either
hypokalaemia, NS1643 or nicorandil. These ﬁndings
are in keeping with our earlier studies using the
hypokalaemic murine heart (Killeen et al. 2007a,b)
and the genetically modiﬁed Brugada syndrome and
Long QT 3 syndrome mouse models (Stokoe et al.
2007a,b, Thomas et al. 2007a,b), which similarly
revealed no gender-related effects.
Experimental solutions
NS1643 was synthesized by the Department of Chem-
istry at NeuroSearch (Ballerup, Denmark). The drug was
initiallypreparedasa100 mmstocksolutionindimethly
sulphoxide (DMSO) and stored at )20  C. Nicorandil
was purchased from Tocris Limited (Bristol, UK) and
was initially prepared as a 10 mm stock solution in
distilled water and stored at )20 C. Subsequent dilu-
tions of both drugs were made in the perfusion buffer.
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+ channels in the murine heartStatistical analysis
MAP data were initially imported into Microsoft excel.
All data are expressed as mean  SEM. Comparisons
were made using anova (spss software) with P < 0.05
being considered signiﬁcant.
Results
Effects of NS1643 and nicorandil on arrhythmogenesis
in spontaneously beating hypokalaemic hearts
Following cannulation and perfusion the electrophysi-
ological parameters of MAP waveform morphology,
amplitude and duration reached a steady state within
10 min. MAP recordings in murine hearts paced at a
basic cycle length (BCL) of 125 ms subsequently
remained highly reproducible throughout the duration
of all experiments.
Extrinsic pacing was then terminated, resulting in a
reduced heart rate (180 beats per minute compared to
480 beats per minute under extrinsic pacing at a BCL
of 125 ms). Bradycardia is a recognized risk factor for
the development of torsade de pointes (Roden &
Hoffman 1985) and earlier studies have reported a
higher prevalence of EADs and associated VT under
bradycardic conditions (Milberg et al. 2002, Fabritz
et al. 2003, Kirchhof et al. 2004, Killeen et al.
2007a,b).
Under control normokalaemic conditions, both epi-
cardial and endocardial waveforms showed no repo-
larization abnormalities and no episodes of VT (n =6 )
(Fig. 1a). However, following the reduction in [K
+]o
from 5.2 to 3 mm, EADs and triggered beats followed
by episodes of non-sustained VT were observed from
all hypokalaemic preparations, from both left ventric-
ular epicardial and endocardial surfaces (n =6 )
(Fig. 1b).
We subsequently tested the anti-arrhythmic efﬁcacy
of NS1643 in the suppression of spontaneously occur-
ring, unprovoked arrhythmogenesis in the hypokalae-
mic murine heart. Following continued perfusion for
20 min, whilst there was a persistence of closely
coupled beats in all the traces obtained, NS1643
suppressed all repolarization abnormalities and sponta-
neous arrhythmias in epicardial recordings from 7 of 13
(54%) hypokalaemic preparations (Fig. 2a).
In preparations perfused instead with nicorandil
(20 lm) for 20 min, neither EADs nor episodes of
unprovoked spontaneous arrhythmias were seen in ﬁve
of six (83%) hypokalaemic preparations (Fig. 2b). We
then proceeded to investigate the basis of these anti-
arrhythmic effects of NS1643 and nicorandil in the
hypokalaemic murine hearts using established arrhyth-
mia provocation protocols.
Effects of NS1643 and nicorandil on provoked
arrhythmogenesis in hypokalaemic hearts
Programmed electrical stimulation was used to deter-
mine the arrhythmic susceptibility produced by extra-
systolic stimulation of hypokalaemic isolated murine
hearts perfused with either 30 lm NS1643 or 20 lm
nicorandil. These standard PES procedures resembled
clinical diagnostic techniques used to assess arrhythm-
ogenic propensity in patients for the current murine
whole heart model at a pacing frequency, which closely
corresponded to the in vivo murine heart rate (Saumarez
& Grace 2000, Balasubramaniam et al. 2003, Yang
et al. 2007). Extrasystolic (S2) stimuli mimicked EADs,
however, producing a signiﬁcantly larger stimulus than
a spontaneously occurring EAD. Short S1-S2 coupling
intervals elicited typical extrasystolic MAPs in hearts in
both normokalaemic and hypokalaemic conditions
(Fig. 3). In all preparations perfused with control
normokalaemic solutions, PES failed to induce VT
(Fig. 3a). In contrast, closely coupled extra stimuli
successfully and reproducibly induced non-sustained
VT in six of six hypokalaemic preparations (Fig. 3b). In
contrast, following perfusion with 30 lm NS1643 for
20 min, PES failed to induce VT with a persistence of
normal regular rhythm in 7 of 13 (54%) hypokalaemic
hearts (Fig. 4a). In parallel with this, in hypokalaemic
hearts perfused with 20 lm nicorandil, PES failed to
induce VT in ﬁve of six hearts (83%) (Fig. 4b).
NS1643 and nicorandil thus exerted an anti-arrhyth-
mic effect in both the spontaneously beating and the
provoked hypokalaemic murine heart. We hypothesized
that these observed anti-arrhythmic effects may be
associated with changes in APD and the left ventricular
transmural gradient of repolarization.
Effects of NS1643 and nicorandil on APD and transmural
gradients of repolarization in hypokalaemic hearts
We therefore proceeded to examine the effects of
hypokalaemia and perfusion with either NS1643 or
nicorandil on APDs recorded from the left ventricular
epicardial and endocardial surfaces to assess whether
the anti-arrhythmic effects of NS1643 and nicorandil
observed in unprovoked, spontaneously beating and
provoked hearts correlated with transmural APD
changes. Measurement of epicardial and endocardial
APD permitted the quantiﬁcation of the left ventricular
transmural gradient of repolarization. We have recently
correlated changes in ventricular repolarization gradi-
ents with arrhythmogenicity in a range of whole heart
murine models (Killeen et al. 2007a,b, Stokoe et al.
2007a,b, Thomas et al. 2007a,b). We accordingly paced
all preparations at a BCL of 125 ms, in keeping with
previous studies (Killeen et al. 2007a,b).
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125 ms, epicardial and endocardial APD90 were
41.9  2.8 and 55.5  2.0 ms respectively (n =6 )
(Fig. 5a). The transmural gradient of repolarization,
reﬂected as DAPD90, was 13.6  4.1 ms (n = 6). Perfu-
sion of normokalaemic hearts with 30 lm NS1643
produced no signiﬁcant effect upon epicardial or endo-
cardial APD90 (47.1  0.7 and 48.5  4.34 ms, respec-
tively),andDAPD90wasreducedto1.4  4.4 ms(n =6 ,
P < 0.05). This reduction in DAPD90 following perfu-
sion of normokalaemic hearts with 30 lm NS1643 was
not associated with arrhythmogenicity in any sponta-
neously beating or provoked heart (n = 6). Perfusion of
normokalaemic hearts with 20 lm nicorandil signiﬁ-
cantly reduced epicardial APD90 to 31.3  1.1 ms
(n =6 ,P < 0.05) yet had no effect upon endocardial
APD90 (56.4  2.7 ms) (n =6 ,P > 0.05). These effects
signiﬁcantly increased DAPD90 to 25.1  2.9 ms (n =6 ,
P < 0.05); however, perfusion of normokalaemic hearts
with 20 lm nicorandil did not induce any arrhythmic
events in any spontaneously beating or provoked heart
(n = 6).
Perfusion of murine hearts with 3 mm [K
+]o led to
signiﬁcant epicardial and endocardial action potential
prolongation. Epicardial APD90 was increased from
41.9  2.8 to 68.3  1.1 ms (n =6 , P < 0.05)
(Fig. 5b). Hypokalaemia produced an appreciable but
not signiﬁcant increase in endocardial APD90 from
55.5  2.0 ms to 58.2  3.3 ms (n =6 , P > 0.05)
(Fig. 5b). These changes in epicardial and endocardial
APD signiﬁcantly reduced DAPD90 from 13.6  4.1 to
)9.6  4.3 ms (n =6 ,P < 0.05) (Fig. 5b), in keeping
(a)
(b)
Figure 1 Representative trace of simul-
taneously recorded left ventricular epi-
cardial and endocardial MAPs from an
isolated, spontaneously beating, Lange-
ndorff-perfused (a) normokalaemic
(5.2 mm [K
+]o) and (b) hypokalaemic
(3 mm [K
+]o) murine heart in the absence
of extrinsic pacing. Under normokalaemic
conditions, no repolarization abnormali-
ties or episodes of ventricular tachycardia
(VT) were ever recorded from any prep-
aration (n = 6). Following perfusion with
hypokalaemic solutions, early afterdepo-
larizations and triggered beats that pre-
ceded episodes of VT were recorded in all
preparations from both epicardial and
endocardial surfaces (n = 6).
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Administration of 30 lm NS1643 to hypokalaemic
preparations produced an appreciable, but not signiﬁ-
cant, reduction in epicardial APD90 from 68.3  1.1 to
56.5  4.1 ms (n = 13, P > 0.05), whilst having no
effect on endocardial APD90 (58.2  3.3 ms vs. 60.4 
0.8 ms, respectively, n = 13, P > 0.05) (Fig. 6a).
Subsequently, perfusion of hypokalaemic hearts with
30 lm NS1643 signiﬁcantly normalized the left ven-
tricular transmural gradient of repolarization, reﬂected
in DAPD90, to 3.9  4.1 ms (n = 13, P < 0.05)
(Fig. 6a).
Perfusion of hypokalaemic hearts with 20 lm nico-
randil similarly produced changes in APD90 and
DAPD90. Nicorandil signiﬁcantly reduced epicardial
APD90 to 51.5  1.5 ms (n =6 ,P < 0.05) whilst hav-
ing no effect upon endocardial APD90 (61.4  1.5 ms
vs. 58.2  3.3 ms respectively) (n =6 , P < 0.05)
(Fig. 6b). These effects of selective, signiﬁcant reduction
in epicardial over endocardial APD following perfusion
with 20 lm nicorandil in the hypokalaemic murine
heart signiﬁcantly normalized DAPD90 to values statis-
tically indistinguishable from control normokalaemic
values (9.9  2.1 ms vs. 13.6  4.1 ms respectively)
(n = 12, P < 0.05) (Fig. 6b).
Perfusion of hypokalaemic hearts with NS1643 and
nicorandil thus produced anti-arrhythmic effects
through the suppression of EADs and triggered activity,
epicardial APD reduction and the correction of altered
transmural gradients of repolarization. These ﬁndings
demonstrate that improving myocardial repolarization
through the pharmacological activation of K
+ channels
is an effective anti-arrhythmic approach in the setting of
hypokalaemia.
3m M [K+]o &3 0µM NS1643








(b) Figure 2 Representative left ventricular
epicardial MAPs recorded from a spon-
taneously beating hypokalaemic heart in
the presence of (a) 30 lm NS1643 and
(b) 20 lm nicorandil. Perfusion of
hypokalaemic hearts with NS1643 or
nicorandil eliminated EADs, triggered
beats and episodes of unprovoked




Figure 3 Programmed electrical stimula-
tion (PES) of isolated, wild-type Lange-
ndorff-perfused mouse hearts under (a)
control normokalaemic conditions and
(b) following perfusion with 3 mm [K
+]o
hypokalaemic buffer solutions. PES failed
to induce ventricular tachycardia (VT) in
any preparation perfused with control,
normokalaemic buffer (n = 6). However,
PES induced VT in six of six hearts per-
fused with 3 mm [K
+]o.
30
  2007 The Authors
Journal compilation   2007 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2007.01773.x
Activation of K
+ channels in the murine heartÆ M J Killeen et al. Acta Physiol 2008, 193, 25–36Discussion
Hypokalaemia is known to predispose to cardiac
arrhythmias at the clinical (Berthet et al. 1999) and
experimental (Killeen et al. 2007a) levels through the
prolongation of APD and the subsequent development
of EADs, which superimpose upon an arrhythmogenic
substrate of altered transmural gradients of repolariza-
tion (Killeen et al. 2007b). At the single cell level, we
previously showed that hypokalaemia reduces transient
outward current (Ito) and inwardly rectifying current
(IK1), effects that are likely to be responsible for APD
prolongation reported at the whole heart level (Killeen
et al. 2007a). Thus, improving myocardial repolariza-
tion through the pharmacological activation of K
+ chan-
nels is an approach that would be expected to reduce
APD and therefore reduce the incidence of EADs and of
subsequent arrhythmogenesis.
We used a recently reported intact murine model of
hypokalaemia-induced arrhythmogenesis (Killeen et al.
(a)
(b)
Figure 4 Programmed electrical stimula-
tion (PES) in isolated, Langendorff-
perfused hypokalaemic murine hearts
following perfusion with (a) 30 lm
NS1643 and (b) 20 lm nicorandil. In the
presence of NS1643 or nicorandil, PES
failed to induce ventricular tachycardia in






















5.2 mM [K+]o 3 mM [K+]o
(a) (b)
Figure 5 Steady-state epicardial and endocardial action
potential duration (APD) measured at 90% repolarization
(APD90), and DAPD90 values (white, black and grey columns
respectively) under (a) control conditions (six hearts) and (b)
following perfusion with 3 mm [K
+]o hypokalaemic solutions
(n = 6). Hypokalaemia prolonged epicardial and endocardial
APD and signiﬁcantly changed the left ventricular transmural



















3 mM [K+]o & 20 µM nicorandil 3 mM [K+]o& 30 µM NS1643 
(a) (b)
Figure 6 Steady-state epicardial and endocardial action
potential duration (APD) measured at 90% repolarization
(APD90), and DAPD90 values (white, black and grey columns
respectively) under hypokalaemic conditions following perfu-
sion with (a) 30 lm NS1643 (n = 13) or (b) 20 lm nicorandil
(n = 6). Both NS1643 and nicorandil reduced epicardial APD
and restored the left ventricular transmural gradient of repo-
larization, DAPD90, to positive values.
  2007 The Authors
Journal compilation   2007 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2007.01773.x 31
Acta Physiol 2008, 193, 25–36 M J Killeen et al.Æ Activation of K
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efﬁcacy of K
+ channel activation in the setting of
hypokalaemia. We report that pharmacological activa-
tion of both HERG and KATP K
+ channels by the novel
compound NS1643 and nicorandil respectively, is an
effective anti-arrhythmic approach in the setting of
hypokalaemia. In the hypokalaemic murine heart,
NS1643 and nicorandil exert these anti-arrhythmic
effects through a suppression of EADs and VT, reduc-
tions in epicardial APD, and a normalization of
transmural gradients of repolarization. We used
NS1643 and nicorandil at concentrations that exceeded
their respective EC50 values to produce a marked
electrophysiological response. Thus, NS1643 was per-
fused at a concentration of 30 lm (EC50 = 10.5 
1.5 lm) (Hansen et al. 2006) and nicorandil was used
at a concentration of 20 lm (EC50 =1 0lm) (Shindo
et al. 1998).
First, in this study, we have shown that perfusion
with NS1643 and nicorandil eliminates EADs, triggered
beats and VT in 7 of 13 (54%) and ﬁve of six (83%)
spontaneously beating hypokalaemic hearts respec-
tively. EADs are critical initiation factors for lethal
arrhythmias in the setting of prolonged APDs (Killeen
et al. 2007a,b; Thomas et al. 2007a,b) and are believed
to be caused by recovery of the L-type calcium channels
(LTCCs) from inactivation, leading to a secondary
inﬂux of Ca
2+ (January & Riddle 1989). We have
recently shown that in the setting of hypokalaemia,
selective inhibition of LTCCs and inhibition of the
LTCC regulator, calmodulin kinase type II reduces
EADs, triggered beats and episodes of spontaneous
arrhythmogenesis associated with hypokalaemia
(Killeen et al. 2007b). Augmenting outward repolariz-
ing K
+ currents would therefore be expected to restore
any imbalance between inward Ca
2+and outward
K
+ currents, acting to impair the formation of EADs
and consequent arrhythmogenesis. In this study, we
show that pharmacological activation of HERG and
KATP K
+ channels by NS1643 and nicorandil, respec-
tively, reduced the occurrence of EADs, triggered beats
and episodes of VT in the spontaneously beating
hypokalaemic murine heart.
Secondly, we quantiﬁed the anti-arrhythmic efﬁcacy
of NS1643 and nicorandil in the hypokalaemic murine
heart by using the established arrhythmia provocation
protocol of PES. Premature stimuli applied during PES
reliably induced VT in all hypokalaemic preparations,
but failed to do so in 7 of 13 (54%) hypokalaemic
hearts perfused with NS1643 and in ﬁve of six (83%)
hypokalaemic hearts perfused with nicorandil.
Finally, we determined whether the anti-arrhythmic
effects of NS1643 and nicorandil were caused by
changes in epicardial and endocardial APD and trans-
mural gradients of repolarization. We have recently
correlated alterations in the transmural gradient of
repolarization with arrhythmogenicity provoked by
imposed extrasystolic stimuli at the whole heart level
in the setting of hypokalaemia (Killeen et al. 2007a,b),
and the LQTS type 3 (Stokoe et al. 2007a, Thomas
et al. 2007a) and type 5 (Thomas et al. 2007b) in
genetically modiﬁed murine hearts.
In this study, perfusion of hypokalaemic hearts with
NS1643 and nicorandil reduced epicardial APD90,
effects that led to the normalization of the murine left
ventricular transmural gradient of APD. We have
recently reported similar ﬁndings using the dihydropir-
idine L-type Ca
2+ channel (LTCC) blocker nifedipine in
hypokalaemic murine hearts (Killeen et al. 2007b) and
in genetically modiﬁed murine hearts following targeted
disruption of the KCNE1 gene to model human LQTS
type 5 (Thomas et al. 2007b). In these studies, nifedi-
pine reduced epicardial APD90, which acted to correct
the altered transmural gradient of repolarization in the
hypokalaemic (Killeen et al. 2007b) and KCNE1
(Thomas et al. 2007b) murine hearts, actions that also
signiﬁcantly reduced arrhythmogenicity. Similarly, in
this study, activation of HERG and KATP K
+ channels,
by NS1643 and nicorandil respectively, in the hypoka-
laemic murine heart reduced epicardial APD90 which
corrected the altered left ventricular transmural gradient
of APD to values similar to those recorded from control,
normokalaemic hearts.
NS1643 is a novel small molecule compound that
activates HERG K
+ channels, leading to a greater
outward repolarizing IKr and a shortening of APD in
isolated ventricular myocytes (Hansen et al. 2006). It
was previously shown that HERG channel overexpres-
sion in rabbit cardiac myocytes reduces the susceptibil-
ity to EADs and shortens APD (Nuss et al. 1999).
Although the predominant repolarizing K
+ current in
the adult mouse ventricle is Ito (Nerbonne et al. 2001),
IKr does contribute to repolarization in the adult murine
heart, albeit to a lesser degree than Ito. Recent studies
have shown that the ion channel proteins that constitute
IKr (mouse ERG transcript, mERG) are abundantly
expressed in the adult murine ventricle, and give rise to
an isolated current at a density similar to that measured
in other mammals (Liu et al. 2004). In ventricular
myocytes isolated from WT mice, a delayed rectiﬁer
current with gating properties similar to IKr in other
species, including inward rectiﬁcation properties at
positive potentials and sensitivity to E-4031, has been
consistently reported (Babij et al. 1998, Liu et al.
2004). Furthermore, speciﬁc block of IKr, using
E-4031, produced AP prolongation in transmembrane
action potentials (TAP) from isolated adult murine
ventricular myocytes (Babij et al. 1998) and in the
intact murine ventricle (Charpentier et al. 1998).
Finally, in the isolated, perfused murine whole heart,
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epicardial APD (Fabritz et al. 2003). Collectively, these
ﬁndings suggest a role of IKr in murine ventricular
repolarization. Despite the reduced role of IKr compared
to Ito in murine cardiac repolarization, here we report,
for the ﬁrst time, that pharmacological activation of the
HERG K
+ channel suppresses spontaneously occurring
EADs, triggered beats and episodes of VT at the whole
heart level.
Nicorandil is an ATP-sensitive potassium (KATP) cha-
nnel opener that has been used extensively as an
antianginal agent in many countries. KATP channels
are members of the inward rectiﬁer ion channel super-
family, and are present at high densities in cardiac
myocytes (Morrissey et al. 2005). KATP channels are
only weak inward rectiﬁers and, therefore, are capable
of passing a substantial outward current (Shivkumar &
Valderrabano 2004). A small number of reports have
suggested that KATP channel openers are efﬁcacious in
the suppression of arrhythmogenesis in the setting of the
LQTS (Shimizu et al. 1998, Shimizu & Antzelevitch
2000). Improving cardiac repolarization through
increases in outward K
+ current carried by pharmaco-
logically activated KATP channels has been shown to
eliminate EADs and episodes of arrhythmogenesis in
LQT1 syndrome patients (Shimizu et al. 1998). In this
study, we show that pharmacological activation of KATP
K
+ channels by nicorandil is an effective anti-arrhythmic
approach in the common clinical condition of hypokal-
aemia.
A problem encountered with KATP channel openers is
a fall in blood pressure and a reﬂex increase in
sympathetic activity, which may be proarrhythmic.
However, compared to other KATP channel openers
such as pinacidil or chromokalim, nicorandil exerts only
a mild hypotensive effect (Spinelli et al. 1990). Further-
more, all clinical case reports documenting the use of
nicorandil for treating cardiac arrhythmias describe an
anti-arrhythmic as opposed to a proarrhythmic effect of
nicorandil (Chinushi et al. 1995); Shimizu et al. 1998).
Indeed, in this study, under normokalaemic control
conditions, nicorandil did not induce EADs, triggered
beats or VT in any preparation and under hypokalaemic
conditions, nicorandil was shown to be anti-arrhythmic.
Short QT syndrome (SQTS) is a recently described
primary electrical disease of the heart, which is charac-
terized by the presence of a QT interval less than
320 ms and a high incidence of ventricular arrhythmo-
genesis (Gussak & Antzelevitch 2000). Previously,
studies genetically mapped SQTS to gain-of-function
mutations in the genes encoding IKr (Brugada et al.
2004), IKs (Bellocq et al. 2004) and IK1 (Priori et al.
2005). These mutations give rise to larger repolarizing
K
+ currents and an expected abbreviation of APD and
QT interval. Theoretically, pharmacological activation
of IKr and IKATP may mimic features of SQTS and could
give rise to potentially lethal episodes of arrhythmia.
However, we consider this unlikely for the following
reasons.
First, a previously reported SQTS N588K gain-of-
function mutation in HERG results in channels, which
do not inactivate at physiological membrane potentials
(Cordeiro et al. 2005). HERG channels treated with
NS1643 behave in a very similar way to WT channels in
the absence of NS1643: following depolarization,
NS1643-activated HERG channels inactivate rapidly
and recover from inactivation, passing an outward
current as the membrane potential recovers (Hansen
et al. 2006). These ﬁndings are in sharp contrast to
mutant N588K channels, which monotonically fol-
lowed the shape and amplitude of the action potential
such that greater outward currents are observed in early
phases of the AP (Cordeiro et al. 2005).
Secondly, the use of nicorandil to activate KATP
channels and cause an increase in repolarizing current
and a consequent shortening of APD and anti-arrhyth-
mic effects in the setting of hypokalaemia is supported
by the documented efﬁcacy of this drug in the clinical
setting (Shimizu et al. 1998). Activation of KATP chan-
nels was previously shown to reduce EADs and prevent
episodes of arrhythmia in patients with congenital
LQTS (Shimizu et al. 1998). Furthermore, at present,
clinical trials of patients with ischaemic heart disease
have revealed no ﬁndings of proarrhythmia associated
with any KATP channel activators (Miyazaki et al. 1995,
Markham et al. 2000). Finally, administration of
nicorandil to patients with acute myocardial infarction
at the time of coronary angioplasty was shown to
reduce episodes of malignant ventricular arrhythmia
(Ito et al. 1999).
Collectively, these ﬁndings suggest: (1) Pharmacolog-
ical activation of HERG channels produces effects,
which are not comparable to those observed with gain-
of-function mutations in HERG comprising variants of
SQTS. (2) Activation of KATP channels by nicorandil
has been shown to be an effective anti-arrhythmic
approach in the setting of impaired myocardial repo-
larization as revealed in the ﬁndings in this study and in
clinical reports from congenital LQTS patients (Shimizu
et al. 1998) in addition to more diverse cardiac diseases
such as myocardial infarction (Ito et al. 1999). We
therefore consider it unlikely that the use of NS1643
and nicorandil in conditions of compromised myocar-
dial repolarization could give rise to an SQTS proar-
rhythmic phenotype.
This study demonstrates that activation of IKr and
IKATP is an effective pharmacological anti-arrhythmic
approach in the setting of hypokalaemia. We previously
demonstrated that hypokalaemia reduces Ito and IK1
(Killeen et al. 2007a) and other studies have reported
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K
+ channels, in situations in which repolarizing
K
+ currents are compromised, could be an important
protective mechanism against lethal arrhythmias. In the
setting of hypokalaemia, correction of serum K
+ is a
relatively safe and effective measure to prevent cardiac
arrhythmias. However, this study acts as a proof of
concept for the pharmacological activation of repolar-
izing K
+ channels in conditions in which K
+ channel
function is reduced. Cardiac diseases comprising heart
failure (Wang et al. 2006), congenital (Splawski et al.
2000) and acquired arrhythmia syndromes (Clancy
et al. 2003) all have altered K
+ channel function as a
common prerequisite. This study, therefore, provides
important information, which validates the anti-ar-
rhythmic efﬁcacy of K
+ channel activation in response
to acquired LQTS conditions, which could potentially
compromise repolarizing K
+ current function and give
rise to lethal arrhythmias.
Taken together, these ﬁndings support the notion that
increased repolarization through activation of HERG
and KATP K
+ channels is an important anti-arrhythmic
mechanism of action by (1) suppression of EADs and
triggered beats that are likely initiating factors for the
development of VT; (2) reductions in myocardial
repolarization times; and (3) normalization of transmu-
ral gradients of repolarization in the left ventricle. The
use of established arrhythmia provocation protocols
conﬁrmed the anti-arrhythmic efﬁcacy of NS1643 and
nicorandil in the hypokalaemic murine heart. In this
study, we demonstrate that nicorandil is more effective
at reducing arrhythmogenicity in the hypokalaemic
murine heart than NS1643. Both nicorandil and
NS1643 were used at concentrations that exceeded
their respective EC50 values to produce signiﬁcant
electrophysiological responses. In the murine heart,
the predominant repolarizing K
+ current is Ito
(Nerbonne et al. 2001). IKr, however, does play a role,
albeit a lesser one than Ito, in murine repolarization
(Fabritz et al. 2003). NS1643 suppressed EADs along-
side spontaneous VT in addition to protecting against
provoked arrhythmias in 7 of 13 preparations in the
setting of hypokalaemia. The reduced efﬁcacy of
NS1643 compared to nicorandil is likely to be due to
the reduced role of IKr in murine ventricular repolari-
zation. Nevertheless, this study shows for the ﬁrst time
in any cardiac preparation that activation of HERG and
KATP K
+ channels is an effective anti-arrhythmic
approach in the murine heart in the setting of the
common clinical condition of hypokalaemia, ﬁndings,
which at the very least merit further testing.
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